Overview
- 13 inspections across 13 sites are on record.
- 30 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
13
Sites
13
Observations
30
Career since
Aug 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Unither Manufacturing LLC. | 15 May 2026 | Human Drugs | On file |
| Eli Lilly and Company | 11 Feb 2026 | Human Drugs | On file |
| Guardian Drug Co. Inc. | 16 Jan 2026 | Human Drugs | |
| Granules Consumer Health Inc. | 3 Dec 2025 | Human Drugs | |
| Menasha Packaging Company, LLC | 6 Nov 2025 | Human Drugs | On file |
Sites inspected
Unither Manufacturing LLC.Rochester, United States1 insp.
Eli Lilly and CompanyConcord, United States1 insp.
Guardian Drug Co. Inc.Dayton, United States1 insp.
Granules Consumer Health Inc.Manassas, United States1 insp.
Menasha Packaging Company, LLCLititz, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Syeda N Mahazabin4 shared
Nelson N Ayangho2 shared
Janet A Rajan2 shared
Lu Chen2 shared
Divek R Jumani1 shared
Alisha B Patel1 shared
Jessica S Estriplet1 shared
Rose L Jean-Mary1 shared
Gam S Zamil1 shared
Paranthaman SenthamaraiKannan1 shared
Full investigator report
Get the verbatim findings behind Young K Chou's 30 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site